Cutaneous T-Cell Lymphoma-Like Eruption from Trimethoprim-Sulfamethoxazole.
Cutaneous pseudolymphoma is a benign reactive process that comprises a heterogeneous group of entities that resembles lymphoma clinically and/or histologically.
APA
Bitar C, Wright A, et al. (2026). Cutaneous T-Cell Lymphoma-Like Eruption from Trimethoprim-Sulfamethoxazole.. The American Journal of dermatopathology. https://doi.org/10.1097/DAD.0000000000003307
MLA
Bitar C, et al.. "Cutaneous T-Cell Lymphoma-Like Eruption from Trimethoprim-Sulfamethoxazole.." The American Journal of dermatopathology, 2026.
PMID
42014023
Abstract
Cutaneous pseudolymphoma is a benign reactive process that comprises a heterogeneous group of entities that resembles lymphoma clinically and/or histologically. This condition can be idiopathic or caused by drugs, infections, or foreign agents. Cutaneous pseudolymphoma could belong to the B-cell type, the T-cell type, or be mixed. The multiple presentations raise a significant diagnostic challenge and require clinicopathologic correlation and follow-up. This case report presents the clinical, histopathologic, immunophenotypic, and genetic findings of a cutaneous T-cell lymphoma-like eruption from trimethoprim-sulfamethoxazole in a 55-year-old female systemic lupus patient.